References
- Delmas PD. Biochemical markers of bone turnover. J Bone Miner Res 1993; 8(Suppl 2)549–55
- Kivirikko KI. Urinary excretion of hydroxy-proline in health and disease. Int Rev Connect Res 1977; 5: 93–163
- Colwell A, Eastell R, Assiri A MA, Russel R GG. Effect of diet on deoxypyridinoline excretion. Osteoporosis, C Christiansen, K Overgaard. Osteopress ApS, Copenhagen 1990; 590–1
- Weiss PH, Klein L. The quantitative relationship of urinary peptide hydroxyproline excretion to collagen degradation. J Clin Invest 1969; 48: 1–10
- Reid K BM, Porler RR. Subunit and structure of subcomponent C1q of the first component of human complement. Biochem J 1976; 155: 10–23
- Pødenphant J, Larsen N-E, Christiansen C. An easy and reliable method for determination of urinary hydroxyproline. Clin Chim Acta 1984; 142: 145–8
- Eyre DR, Koop TJ, Van Ness KP. Quantitation of hydroxypyridinium crosslinks in collagen by high-performance liquid chromatography. Anal Biochem 1984; 137: 380–8
- Eyre DR, Dickson IR, Van Ness K. Collagen crosslinking in human bone and articular cartilage. J Biochem 1988; 252: 495–500
- Eyre DR, Paz MA, Galop PM. Cross-linking in collagen and elastin. Ann Rev Biochem 1984; 53: 717–48
- Seyeden EM, Kung VT, Daniloff YN, Hesley RP, Gomez B, Nielsen LA. Immunoassay for urinary pyridinoline: the new marker for bone resorption. J Bone Miner Res 1993; 8: 635–41
- Bonde M, Qvist P, Fledelius C, Riis BJ, Christiansen C. Immunoassay for quantifying type I collagen degradation products in urine evaluated. Clin Chem 1994; 40: 2022–5
- Hanson DA, Weis M AE, Bollen A-M, Maslan SL, Singer FR, Eyre DR. A specific immunoassay for monitoring human bone resorption; quantitation of type I collagen cross-linked N-telopeptides in urine. J Bone Miner Res 1992; 7: 1251–8
- Risteli J, Elonaa I, Niemi S, Novamo A, Risteli L. Radioimmunoassay for pyridinoline cross-linked carboxy-terminal telopeptide of type I collagen: a new serum marker of bone collagen degradation. Clin Chem 1993; 39: 635–40
- Bonde M, Qvist P, Fledelius C, Riis BJ, Christiansen C. Applications of an enzyme immunoassay for a new marker of bone resorption (CrossLaps): follow-up on hormone replacement therapy and osteoporosis risk assessment. J Clin Endocrinol Metab 1995; 80: 864–8
- Garnero P, Gineyts E, Arbault P, Christiansen C, Delmas PD. Different effects of bisphosphanate and estrogen therapy on free and peptide-bound bone crosslinks excretion. J Bone Miner Res 1995; 79: 780–85
- Bjarnason N, Bjarnason K, Haarbo J, Rosenquist C, Christiansen C. Tibolone: prevention of bone loss in elderly postmenopausal women. J Clin Endocrinol Metab 1996; 81: 2419–22
- Soinila S, Mpitsos GJ, Soinila J. Immuno-histochemistry of enkephalins: model studies on hapten-carrier conjugates and fixation methods. J Histochem Cytochem 1992; 40: 231–9
- Rosenquist C, Bonde M, Fledelius C, Qvist P. A simple enzyme-linked immunosorbent assay of human osteocalcin. Clin Chem 1994; 40: 1258–64
- Meyer K, Behringer DM, Veh RW. Antibodies against neuroactive amino acids and neuro-peptides. I. A new two-step procedure for their conjugation to carrier proteins and the production of an anti-met-enkephalin antibody reactive with glutaraldehyde-fixed tissues. J Histochem Cytochem 1991; 39: 749–60
- Kearney JF, Radbruch LiesegangB, Rajewsky K. A new mouse myeloma cell line that has lost immunoglobulin expression but permits the construction of antibody-secreting hybridoma cell lines. J Immunol 1979; 123: 1548–50
- Astaldi G GB, Janssen MC, Lansdorp P, Willems C, Zeijlemarker WP, Oosterhof F. Human endo-thelial supernatants (HECS): a growth factor for hybridomas. J Immunol 1980; 25: 1411–14
- Ishikawa E. Enzyme-labelling of antibodies. J Immunoassay 1983; 4: 209–327
- SAS Institute. SAS/STAT guide for personal computers6th ed. SAS Institute, Cary, North Carolina 1987
- Kühn K. Clinical properties of collagen. Immunochemistry of the extracellular matrix, H Furthmayer. CRC Press, Boca Raton, Florida 1982; 1–30
- Kadler K. Extracellular matrix 1: fibril-forming collagens. Protein profiles. 1994; 1: 517–638
- Fledelius C, Riis BJ, Overgaard K, Christiansen C. The diagnostic validity of urinary free pyridinolines to identify women at risk of osteoporosis. Calcif Tissue Int 1994; 54: 381–4
- Frijlink WB, Bijvoet O LM, Te Velde J, Heynen G. Treatment of Paget's disease with (3-amino-1-hydroxy-propylidene)-1–1-bisphosphonate (APB). Lancet 1979; i: 799–801